Growth Metrics

Inspire Medical Systems (INSP) Cash from Investing Activities (2017 - 2026)

Inspire Medical Systems' Cash from Investing Activities history spans 10 years, with the latest figure at -$11.2 million for Q1 2026.

  • On a quarterly basis, Cash from Investing Activities fell 624.34% to -$11.2 million in Q1 2026 year-over-year; TTM through Mar 2026 was $11.8 million, a 112.35% increase, with the full-year FY2025 number at $21.4 million, up 118.96% from a year prior.
  • Cash from Investing Activities hit -$11.2 million in Q1 2026 for Inspire Medical Systems, up from -$11.9 million in the prior quarter.
  • Over the last five years, Cash from Investing Activities for INSP hit a ceiling of $46.6 million in Q2 2025 and a floor of -$151.7 million in Q4 2023.
  • Historically, Cash from Investing Activities has averaged -$24.5 million across 5 years, with a median of -$3.8 million in 2022.
  • Biggest five-year swings in Cash from Investing Activities: tumbled 5043.15% in 2023 and later surged 728.51% in 2025.
  • Tracing INSP's Cash from Investing Activities over 5 years: stood at -$2.9 million in 2022, then tumbled by 5043.15% to -$151.7 million in 2023, then soared by 102.48% to $3.8 million in 2024, then tumbled by 416.88% to -$11.9 million in 2025, then grew by 5.61% to -$11.2 million in 2026.
  • Business Quant data shows Cash from Investing Activities for INSP at -$11.2 million in Q1 2026, -$11.9 million in Q4 2025, and -$11.6 million in Q3 2025.